COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,280 Articles (22,759 medRxiv, 8,521 bioRxiv)

Most recent first Previous |  Page 243: Articles 2421-2430  | Next

High transferability of neutralizing antibodies against SARS-CoV-2 to umbilical cord blood in pregnant women with BNT162b2 XBB.1.5 vaccine - a retrospective cohort study
Hayashi, T., Sano, K., Konishi, I.
10.1101/2024.03.18.24304517 — Posted: 2024-03-19
Postpartum suicidal ideation in Austria and Germany during the COVID-19 pandemic
Florea, C., Preiss, J., Angerer, M., Schabus, M.
10.1101/2024.03.15.24304383 — Posted: 2024-03-18
Role of the complement system in Long COVID
Farztdinov, V., Zuehlke, B., Sotzny, F., Steinbeis, F., Seifert, M., Kedor, C., Wittke, K., Tober-Lau, P., Textoris-Taube, K., Ludwig, D., Dierks, C., Bierbaum, D., Sander, L. E., Hanitsch, L. G., Witzenrath, M., Kurth, F., Muelleder, M., Scheibenbogen, C., Ralser, M.
10.1101/2024.03.14.24304224 — Posted: 2024-03-18
Exploring Machine Learning Strategies in COVID-19 Prognostic Modelling: A Systematic Analysis of Diagnosis, Classification and Outcome Prediction
Najjar, R., Hossain, M. Z., Ahmed, K. A., Hasan, M. R.
10.1101/2024.03.17.24304450 — Posted: 2024-03-18
Real-world Nuvaxovid COVID-19 vaccine safety profile after first 100,000 doses in Australia, 2022-2023
Clothier, H. J., Parker, C., Mallard, J. H., Effler, P., Bloomfield, L., Carcione, D., Buttery, J. P.
10.1101/2024.03.17.24304409 — Posted: 2024-03-18
Publication status of 95 clinical trials of 3 COVID-19 vaccines developed by Chinese companies: An observational cohort study
Bruckner, T., Chen, Y., Cruz, C., Dike, C. E., Chavarria, B., Chen, S., Dzidzornu, E. D.
10.1101/2024.03.17.24304386 — Posted: 2024-03-18
Mental Health Trends in India from 2020 to 2022: Association with Financial Stress, Food Insecurity, and COVID-19-related Illness Concerns
Yang, Y., Sun, A., Zimmermann, L., Mukherjee, B.
10.1101/2024.03.17.24304396 — Posted: 2024-03-18
Identification of unique and potent inhibitors of SARS-CoV-2 main protease from DNA-encoded chemical libraries
Akaberi, D., Pourghasemi Lati, M., Krambrich, J., Berger, J., Strandback, E., Turunen, P., Gullberg, H., Moche, M., Chinthakindi, P. K., Nyman, T., Sandstrom, A., Jarhult, J. D., Sandberg, K., Lundkvist, A., Verho, O., Lennerstrand, J.
10.1101/2024.03.16.585341 — Posted: 2024-03-18
Modulation of SARS-CoV-2 spike binding to ACE2 throughconformational selection
Saha, P., Fernanadez, I., Sumbul, F., Valotteau, C., Kostrz, D., Meola, A., Baquero, E., Sharma, A., Portman, J. R., Stransky, F., Boudier, T., Guardado Calvo, P., Gosse, C., Strick, T., Rey, F. A., Rico, F.
10.1101/2024.03.15.585207 — Posted: 2024-03-18
IDRWalker: A Random Walk based Modeling Tool for Disordered Regions in Proteins
Chen, G., Zhang, Z.
10.1101/2024.03.17.585378 — Posted: 2024-03-18

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).